Latest News: Proscia Receives FDA 510(k) Clearance For Concentriq AP-DxREAD THE PRESS RELEASE

Proscia Announces Major Expansion In Preclinical R&D To Drive Faster Drug Safety Decisions

By Author Proscia | March 20, 2023

Proscia is enhancing its flagship Concentriq® for Research, trusted by 14 of the top 20 pharmaceutical companies as a singular software platform for pathology workflows and data, to accelerate Good Laboratory Practice (GLP) and non-regulated drug safety studies.

Our website uses cookies. By using this site, you agree to its use of cookies.